Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Glycosylation. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN106543244A details enzymatic synthesis of galactosyl salidroside. Offers high yield, mild conditions, and cost-effective manufacturing for pharmaceutical supply chains.
Advanced stereospecific synthesis of beta-thymidine via CN1055293C. Offers cost reduction in API manufacturing with high purity and scalable industrial processes.
Patent CN103087132A reveals oxidizing agent method for beta-nucleosides. Enhances supply chain reliability and reduces manufacturing costs for pharmaceutical intermediates.
Novel 3+2 coupling route for fondaparinux sodium intermediate ensures high purity and scalable production for global pharmaceutical supply chains.
Patent CN105218600B reveals a high-yield synthesis route for mannose derivatives, offering significant cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Novel synthesis of water-soluble beta-elemene glycosides via trichloroacetimidate and bromosugar methods. Enhanced solubility for anticancer applications.
Patent CN1376159A details a high-yield Etoposide synthesis using TMSOTf. Discover cost-effective manufacturing and supply chain advantages for pharmaceutical intermediates.
Patent CN1910194A details a mercury-free spongosine synthesis route offering high purity and scalability for cost reduction in API manufacturing.
Patent CN112724180A reveals a high-yield chemical route for beta-nicotinamide mononucleotide, offering cost reduction and scalable manufacturing for global supply chains.
Novel patent CN110183427A offers efficient synthesis for pharmaceutical intermediates. Reduces toxic reagents and improves total yield to 42.2% for scalable production.
Patent CN106831927A details high-yield Astragaloside IV synthesis. Offers cost reduction and supply reliability for pharmaceutical intermediate manufacturing.
Patent CN101279993A details a modular Suzuki coupling route for 3-aryl-8-hydroxychromone derivatives, offering cost-effective API intermediate manufacturing.
Patent CN108440473A reveals a high-yield synthesis for Marangucycline B intermediates, offering cost reduction and scalable supply chain solutions for pharmaceutical manufacturing.
Novel stereoselective method for 4-MU glycosides using peracetyl sugars. Enhances purity and supply chain reliability for diagnostic reagents.
Patent CN101279993B details a robust Suzuki coupling route for 3-aryl-8-hydroxychromone derivatives. Discover cost-effective manufacturing strategies for alpha-glucosidase inhibitors.
Patent CN111377989B reveals a high-selectivity synthesis for decitabine intermediates, offering superior beta-isomer ratios and scalable purification for cost-effective API manufacturing.
Patent CN108794653B discloses synthetic fucosylated chondroitin sulfate clusters with defined structures. Offers cost reduction in anticoagulant manufacturing and reliable supply chain solutions.
Advanced preparation method for 4-demethoxy-4-aminoanthracycline compounds via novel sulfonate intermediates. Enhances purity and supply chain reliability for API manufacturing.
Patent CN119019478B reveals novel glycosylation method for Type II Lipoteichoic Acid. Enables scalable production and cost reduction for pharmaceutical intermediates.
Patent CN119019478A reveals a novel glycosylation method for Type II lipoteichoic acid, offering high conversion and scalable manufacturing for immunological research.